Before submitting an abstract, the submitter must create a simple User Profile with their name, email address, and credentials. This enables them to log back into the abstract submission site. After an abstract has been created, modifications can be made until the submission deadline. There is no limit on the number of abstract submissions from any one individual.
The final deadline to submit the abstract(s) is September 13th. Abstracts will not be able to be submitted online after this date. At the time of the confirmation of acceptance of your abstract, presenters will be requested to register for the meeting. Deadline for abstract confirmation of acceptance and presenter registration is October 17, 2019. All accepted abstract authors will have the opportunity to present their abstracts during the mini-oral presentations on-site at the International Transplantation Science Meeting.
Abstract submissions should broadly pertain to all aspects of both basic and translational transplant science.
All abstracts should be formatted into the following four sections:
- Introduction: clarifies the motivation for the research presented.
- Methods: provides enough detail for others to reproduce what is studied in the research project.
- Results: presents and discusses the results.
- Conclusion: presents the outcome of the work by interpreting the findings and by relating these findings to the motivation stated in the Introduction. Explain the significance of your findings/outcomes and future implications of the results.
The abstract total text is limited to 3,000 characters including spaces.
A maximum of four figures/images (in JPG, GIF, or PNG with ideally 600 dpi) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups. File size of 50 MB maximum for each figure.
Tables: do not insert tables into the body of the abstracts, the system will not recognize the format of the table. Tables will need to be uploaded as an image.
All abstracts must be submitted electronically through the ITS abstract submission website.
- Abstracts will be accepted in English only
- There is no fee for submitting an abstract
- There are no limitations on the number of abstracts that an individual can submit.
- Abstracts accepted for presentation will be included in the ITS 2019 Program. If the presenter is not officially registered for the meeting by the October 17th deadline, the abstract will not be included in the program. Abstracts will also be posted prior to the ITS Meeting on the detailed program of the meeting website.
- Employees of Commercial Entities: AST, ESOT, and TSS recognize that employees of commercial entities are often involved in research and discovery and encourages these employees to submit abstracts to facilitate the ﬂow of new information. Employees of commercial entities should submit abstracts when the content is limited to basic science research (e.g., pre-clinical research, drug discovery) or the processes/methodologies of research, themselves unrelated to a specific disease or compound/drug, and the abstract is not related to clinical applications of the research/discovery or clinical recommendations concerning the business lines or products of their employer.
- Ensure that all co-authors approve of the abstract submission, publication, and potential presentation. Abstracts cannot be changed or withdrawn after September 13, 2019. Once the abstract has been scored by reviewers, no change in the body of the abstract will be accepted.
A number of Mentee-Mentor awards will be given for the highest scoring abstracts that meet the eligibility criteria.
We will use poster boards that are 6 ft (1.8 m) WIDE by 4 ft (1.2 m) HIGH. These are less wide than traditional 8 ft (2.4 m) wide poster boards. Please create your poster to cover most of the board surface.